IR
IRMD
IRADIMED CORP
$93.60
-2.76%
$1.2B
No data for this timeframe.
Vol
Market Cap$1.2B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders50 funds
Inst. Value$424.7M
Inst. Activity12 buys / 5 sells
Insider Activity0B / 27S
Insider Net $-$5.9M
SEC Reports4
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001325618·Prev Close $96.26
Recent Activity
Jun 4, 2026
SEC
Two IRMD insiders—CEO Roger Susi and Director Hilda Scharen-Guivel—made open-market sales totaling ~$203K over a four-da
CLUSTER — Impact 3/10
Jun 4, 2026
Insider
Scharen-Guivel Hilda Frederique sold 1,766 shares
Director @ $95.00 ($167.8K)
Jun 1, 2026
Insider
Susi Roger E. sold 400 shares
CEO, President, Chairman @ $88.68 ($35.5K)
May 27, 2026
Insider
Susi Roger E. sold 2,167 shares
CEO, President, Chairman @ $91.85 ($199.0K)
May 20, 2026
SEC
iRadimed reported Q1 2026 EPS of $0.49, beating consensus of $0.44 by 11.4%, with revenue of $20.4M in line with estimat
PRESS-RELEASE — Impact 3/10
May 1, 2026
SEC
iRadimed reported Q1 2026 revenue of $22.0M (+13% YoY) and GAAP diluted EPS of $0.45 (+22% YoY), beating consensus estim
PRESS-RELEASE — Impact 7/10
Inst.
Nuveen, LLC — DOUBLED
86,129 shares ($8.3M)
Inst.
TUDOR INVESTMENT CORP ET — DOUBLED
71,836 shares ($6.9M)
Price Targets
$118.00
+26.1% upside
Strong Buy
Current $93.60
Low $116.00
Median $118.00
High $120.00
2 analysts
$116.00
$120.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 2, 2026 | Freedom Broker | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.44 ▼ -5.4% | $0.44 — $0.44 | -10% YoY | 2 |
| Next Q | $0.54 ▼ -0.9% | $0.53 — $0.55 | 15% YoY | 2 |
| Current FY | $2.08 | $2.07 — $2.08 | 8% YoY | 2 |
| Next FY | $2.35 ▲ +1.5% | $2.32 — $2.39 | 13% YoY | 2 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Two IRMD insiders—CEO Roger Susi and Director Hilda Scharen-Guivel—made open-market sales totaling ~$203K over a four-da
Jun 4, 2026
NEUTRAL
PRESS-RELEASE
3/10
iRadimed reported Q1 2026 EPS of $0.49, beating consensus of $0.44 by 11.4%, with revenue of $20.4M in line with estimat
May 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $93.2M | — |
| RENAISSANCE TECHNOLOGIES LLC | $42.4M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $34.5M | — |
| KAYNE ANDERSON RUDNICK INVESTMENT | $33.6M | NEW |
| DIMENSIONAL FUND ADVISORS LP | $21.8M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Scharen-Guivel Hilda | SELL | $167.8K |
| Jun 1, 2026 | Susi Roger | SELL | $35.5K |
| May 27, 2026 | Susi Roger | SELL | $199.0K |
| May 26, 2026 | Susi Roger | SELL | $285.6K |
| May 19, 2026 | Susi Roger | SELL | $56.9K |
50 institutional holders with $424.7M total value (4,412,009 shares) as of 2026-Q1. Top holders: BlackRock,, RENAISSANCE, VANGUARD. Net buying activity: 12 institutions added/increased vs 5 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 967,787 | $93.2M | 21.9% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 440,712 | $42.4M | 10.0% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 358,620 | $34.5M | 8.1% | — |
| 4 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 349,316 | $33.6M | 7.9% | NEW |
| 5 | DIMENSIONAL FUND ADVISORS LP | 226,146 | $21.8M | 5.1% | — |
| 6 | STATE STREET CORP | 204,528 | $19.7M | 4.6% | — |
| 7 | GOLDMAN SACHS GROUP INC | 197,945 | $19.1M | 4.5% | — |
| 8 | TWO SIGMA INVESTMENTS, LP | 165,669 | $15.9M | 3.8% | ADD +33.4% |
| 9 | MORGAN STANLEY | 149,839 | $14.4M | 3.4% | ADD +39.1% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 122,425 | $11.8M | 2.8% | — |
| 11 | Russell Investments Group, Ltd. | 99,498 | $9.6M | 2.3% | TRIM -30.3% |
| 12 | Nuveen, LLC | 86,129 | $8.3M | 2.0% | DOUBLED +268.7% |
| 13 | ENVESTNET ASSET MANAGEMENT INC | 75,460 | $7.3M | 1.7% | — |
| 14 | SEI INVESTMENTS CO | 74,304 | $7.2M | 1.7% | DOUBLED +163.8% |
| 15 | TUDOR INVESTMENT CORP ET AL | 71,836 | $6.9M | 1.6% | DOUBLED +130.4% |
| 16 | FMR LLC | 67,069 | $6.5M | 1.5% | DOUBLED +226.2% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 65,440 | $6.3M | 1.5% | — |
| 18 | VANGUARD FIDUCIARY TRUST CO | 56,046 | $5.4M | 1.3% | — |
| 19 | LAZARD ASSET MANAGEMENT LLC | 48,914 | $4.7M | 1.1% | — |
| 20 | PRUDENTIAL FINANCIAL INC | 36,165 | $3.5M | 0.8% | DOUBLED +257.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Nuveen, LLC | DOUBLED | 23,362 | 86,129 | +268.7% | $8.3M | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 31,177 | 71,836 | +130.4% | $6.9M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | DOUBLED | 10,110 | 36,165 | +257.7% | $3.5M | 2026-Q1 |
| Invesco Ltd. | TRIM | 35,131 | 18,662 | -46.9% | $1.8M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 6,309 | 15,445 | +144.8% | $1.5M | 2026-Q1 |
| HSBC HOLDINGS PLC | TRIM | 21,559 | 15,357 | -28.8% | $1.5M | 2026-Q1 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | TRIM | 25,946 | 14,613 | -43.7% | $1.4M | 2026-Q1 |
| Point72 Asset Management, L.P. | ADD | 10,982 | 14,319 | +30.4% | $1.4M | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 15,828 | 11,551 | -27.0% | $1.1M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | ADD | 4,865 | 7,622 | +56.7% | $733.7K | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | ADD | 2,649 | 3,933 | +48.5% | $378.6K | 2026-Q1 |
| Trexquant Investment LP | TRIM | 4,320 | 3,208 | -25.7% | $308.8K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | 14 | 165 | +1078.6% | $15.9K | 2026-Q1 |
| BROWN BROTHERS HARRIMAN & CO | DOUBLED | 54 | 117 | +116.7% | $11.3K | 2026-Q1 |
| Allworth Financial LP | ADD | 47 | 65 | +38.3% | $6.3K | 2026-Q1 |
| HRT FINANCIAL LP | ADD | 26,570 | 47,537 | +78.9% | $4.6K | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 4,782 | 6,184 | +29.3% | $596.00 | 2026-Q1 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | NEW | — | 333,229 | — | $32.4M | 2025-Q4 |
| FMR LLC | DOUBLED | 20,458 | 66,732 | +226.2% | $6.5M | 2025-Q4 |
| SEI INVESTMENTS CO | DOUBLED | 24,028 | 63,396 | +163.8% | $6.2M | 2025-Q4 |
| Invesco Ltd. | DOUBLED | 6,121 | 35,131 | +473.9% | $3.4M | 2025-Q4 |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 9,360 | 31,177 | +233.1% | $3.0M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 20,423 | 30,311 | +48.4% | $2.9M | 2025-Q4 |
| CREDIT AGRICOLE S A | DOUBLED | 7,300 | 21,698 | +197.2% | $2.1M | 2025-Q4 |
| FRANKLIN RESOURCES INC | ADD | 11,348 | 15,828 | +39.5% | $1.5M | 2025-Q4 |
5 unique insiders with 29 transactions. Net insider value: -$5.9M ($0.00 bought, $5.9M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Scharen-Guivel Hilda Frederique | Director | SELL | 1,766 | $95.00 | $167.8K |
| Jun 1, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 400 | $88.68 | $35.5K |
| May 27, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 2,167 | $91.85 | $199.0K |
| May 26, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 3,111 | $91.81 | $285.6K |
| May 19, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 653 | $87.13 | $56.9K |
| May 18, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 298 | $85.95 | $25.6K |
| May 12, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 3,307 | $83.70 | $276.8K |
| May 11, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 1,773 | $84.08 | $149.1K |
| May 5, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 600 | $83.78 | $50.3K |
| May 4, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 2,447 | $85.32 | $208.8K |
| Apr 28, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 998 | $84.13 | $84.0K |
| Apr 27, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 2,819 | $88.98 | $250.8K |
| Apr 21, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 1,162 | $89.73 | $104.3K |
| Apr 20, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 3,580 | $93.14 | $333.4K |
| Apr 14, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 2,107 | $93.71 | $197.4K |
| Apr 13, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 1,847 | $91.84 | $169.6K |
| Apr 7, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 1,518 | $94.36 | $143.2K |
| Apr 6, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 1,357 | $95.21 | $129.2K |
| Mar 30, 2026 | Susi Roger E. | CEO, President, Chairman | SELL | 5,848 | $94.81 | $554.4K |
| Mar 24, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 1,585 | $100.03 | $158.5K |
| Mar 23, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 2,950 | $99.58 | $293.8K |
| Mar 17, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 2,500 | $102.43 | $256.1K |
| Mar 16, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 3,009 | $101.18 | $304.5K |
| Mar 10, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 2,500 | $100.11 | $250.3K |
| Mar 9, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 5,000 | $100.04 | $500.2K |
| Mar 6, 2026 | Susi Roger E. | CEO, PRESIDENT, CHAIRMAN | SELL | 6,300 | $98.25 | $619.0K |
| Mar 3, 2026 | Chiprin Jeff | Chief Commercial Officer | AWARD | 1,150 | — | — |
| Mar 3, 2026 | GLENN JOHN | CHIEF FINANCIAL OFFICER | AWARD | 8,907 | — | — |
| Feb 13, 2026 | ALLEN MONTY K | Director | SELL | 1,000 | $100.26 | $100.3K |
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.0/10.
NEUTRAL
CLUSTER
3/10
Two IRMD insiders—CEO Roger Susi and Director Hilda Scharen-Guivel—made open-market sales totaling ~
Jun 4, 2026
NEUTRAL
PRESS-RELEASE
3/10
iRadimed reported Q1 2026 EPS of $0.49, beating consensus of $0.44 by 11.4%, with revenue of $20.4M
May 20, 2026
BULLISH
PRESS-RELEASE
7/10
iRadimed reported Q1 2026 revenue of $22.0M (+13% YoY) and GAAP diluted EPS of $0.45 (+22% YoY), bea
May 1, 2026
NEUTRAL
PRESS-RELEASE
3/10
iRadimed (IRMD) announced it will release Q1 2026 financial results on May 1, 2026, ahead of the mar
Apr 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$118.00 mean target
+26.1% upside
Strong Buy (3.00)
$116.00 Low
$120.00 High
| Metric | Value |
|---|---|
| Current Price | $93.60 |
| Target Low | $116.00 |
| Target Mean | $118.00 |
| Target Median | $118.00 |
| Target High | $120.00 |
| # Analysts | 2 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.44 | $0.44 | $0.44 | -10.2% | -5.4% | 0↑ 1↓ | $0.0B | -0.3% | 2 |
| Next Q 2026-09-30 |
$0.54 | $0.53 | $0.55 | 14.9% | -0.9% | 0↑ 1↓ | $0.0B | 11.6% | 2 |
| Current FY 2026-12-31 |
$2.08 | $2.07 | $2.08 | 7.5% | -0.2% | 1↑ 0↓ | $0.1B | 8.8% | 2 |
| Next FY 2027-12-31 |
$2.35 | $2.32 | $2.39 | 13.5% | +1.5% | — | $0.1B | 10.6% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.440 | |
| 7d ago | $0.465 | -0.025 |
| 30d ago | $0.465 | -0.025 |
| 60d ago | $0.465 | -0.025 |
| 90d ago | $0.490 | -0.050 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 2, 2026 | Freedom Broker | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 20, 2026
earnings
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
<p>ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical dev
May 4, 2026
earnings_calendar
IRMD Q1 2026 Earnings Scheduled — 2026-05-04
May 1, 2026
earnings
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
<p align="center"><strong>Announces Regular Quarterly Cash Dividend of $0.20 Per Share </strong></p>
May 1, 2026
earnings_calendar
IRMD Q1 2026 Earnings Scheduled — 2026-05-01
Apr 27, 2026
earnings
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
<p>ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 firs
Apr 24, 2026
earnings_calendar
IRMD Q1 2026 Earnings Scheduled — 2026-04-24
Apr 10, 2026
other
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
<p>ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the <strong>25t
Mar 16, 2026
other
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
<p>ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the <strong>38<
Mar 13, 2026
short_interest
FTD: IRMD — 12,136 shares ($1.2M) failed to deliver
Settlement: 20260313, Price: $99.37, FTD Value: $1,205,954.32, IRADIMED CORP COM
Mar 12, 2026
short_interest
FTD: IRMD — 12,392 shares ($1.2M) failed to deliver
Settlement: 20260312, Price: $100.81, FTD Value: $1,249,237.52, IRADIMED CORP COM
Mar 11, 2026
short_interest
FTD: IRMD — 12,382 shares ($1.2M) failed to deliver
Settlement: 20260311, Price: $98.95, FTD Value: $1,225,198.9, IRADIMED CORP COM
Mar 10, 2026
short_interest
FTD: IRMD — 7,419 shares ($0.7M) failed to deliver
Settlement: 20260310, Price: $100.18, FTD Value: $743,235.42, IRADIMED CORP COM